AFT Pharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAAFT Pharmaceuticals Limited (AFP) is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties.
AFT's products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.
Its featured brand includes Crystaderm, coco-scalp and maxigesic.
Contact Details
Level 1, 129 Hurstmere Road, AUCKLAND New Zealand 0622
+64 9 488 0232
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1013th | AFT Pharmaceuticals | -10% | 1% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | AFT Pharmaceuticals | $181.0m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Andrew Lane, Non-Executive Director | 03 Jul 2024 |
| NEW ROLE: Ted Witek, Non-Executive Director | 17 Jan 2021 |
| NEW ROLE: Anita Baldauf, Non-Executive Director | 13 Nov 2020 |
| NEW ROLE: Jon Lamb, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: David Flacks, Non-Executive Chair | 03 Nov 2020 |
| NEW ROLE: Doug Wilson, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Marree Atkinson, Chief of Staff, Managing Director | 03 Nov 2020 |
| NEW ROLE: Hartley Atkinson, Founder, Chief Executive Officer, Executive Director | 03 Nov 2020 |
| NEW ROLE: Jim Burns, Non-Executive Director | 03 Nov 2020 |
